Increasing sterile syringe access through syringe exchange programs and non-prescription pharmacy sales is essential to reducing syringe sharing among injection drug users and decreasing rates of HIV/AIDS and hepatitis C transmission. Syringe exchange programs have also been shown to increase the safe disposal of used syringes, protecting police officers and the public from accidental exposure to blood-borne diseases.
Despite the benefits of these life-saving programs, legal and bureaucratic barriers still prevent injection drug users from accessing clean syringes. The Drug Policy Alliance has led efforts to increase syringe access in several states and is playing a key role in repealing the federal syringe funding ban. We continue to push for reforms that would greatly reduce rates of disease transmission, overdose and other risks associated with injection drug use.
For more than two decades, removal of the ban on federal funding for syringe exchange programs (SEPs) was a top policy priority for amfAR. Following the removal of the ban by Congress in December 2009, amfAR is now working to encourage effective implementation of federal support for SEPs and to ensure the continued availability of federal resources for these evidence-based HIV prevention programs.
Protecting Law Enforcement from Needle Stick Injuries - Made in cooperation with the Los Angeles Police Department (LAPD), this educational documentary explains how officers can reduce the risk of infection by needle sticks on the job. LAPD officers visit a needle exchange on their beat and explore the ways that Needle Exchange Programs help keep law enforcement officers and their communities safer. Produced by Gretchen Hildebran.
These fact sheets focus on HIV prevention issues related to syringes.
911 Good Samaritan
In September 2012, California Governor Jerry Brown signed AB 472, the '911 Good Samaritan' overdose death prevention bill, into law. The law, which goes into effect January 1st, 2013, encourages people to call 911 during an overdose by providing limited immunity for low-level drug law violations, such as possession of a small amount of drugs. DPA worked closely with our allies for years to get this life-saving legislation passed, and we are now helping to raise awarenesss of the law.
Bill Would Allow Over-the-Counter Sales of Limited Numbers of Syringes in Pharmacies
Public Health and HIV Prevention Advocates Urge Passage of Life-Saving Legislation
Trenton - On Thursday, February 17th, the New Jersey State Senate will consider life-saving legislation to allow for the sale of limited numbers of syringes in pharmacies without a prescription. The senate voting session is scheduled to begin at 2PM. New Jersey is one of only two states (the other state is Delaware) that completely ban over-the-counter sales of syringes.
Legislation Passes 28-12 with Bi-Partisan Support
Public Health and HIV Prevention Advocates Cheer Passage of Life-Saving Legislation
Trenton—Today, the New Jersey State Senate passed life-saving legislation to allow for the sale of limited numbers of syringes in pharmacies without a prescription. The legislation received bi-partisan support, passing by a vote of 28-12. New Jersey is one of only two states (the other state is Delaware) that completely ban over-the-counter sales of syringes.
Committee Scheduled for Thursday, January 20, 1 p.m.; Bill Would Allow Over-the-Counter Sale of Limited Numbers of Syringes in Pharmacies
Public Health, and HIV Prevention Advocates Urge Passage of Life-Saving Legislation
Trenton—On Thursday, January 20, the New Jersey Senate Health, Human Services and Senior Citizens Committee will consider life-saving legislation to allow for the sale of limited numbers of syringes in pharmacies without a prescription. The hearing will be held at 1 p.m. in Committee Room 1 on the first floor of the statehouse annex. New Jersey is one of only two states (the other state is Delaware) that completely ban over-the-counter sale of syringes.
States Could Use Federal Money to Distribute Sterile Syringes to Reduce HIV/AIDS and Hepatitis C as Soon as Obama Signs the Bill into Law; Washington, D.C. Could Join 13 States in Allowing Patients to Grow and Use Marijuana for Medical Use
Reforms Part of Growing Momentum in Support of Ending the Failed War on Drugs
Commissioned by the Drug Policy Alliance
This report highlights the connections between New Jersey's restrictive distribution scheme for sterile syringes and the incidence of HIV/AIDS and Hepatitis C among injection drug users. The recommendation we offer in this report is simple and straightforward: Any steps New Jersey can take to increase access to sterile syringes should be immediately incorporated into a strong, aggressive public health strategy to combat injection drug use.